Tatu A. Miettinen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tatu A. Miettinen has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Helena Gylling
Department of Clinical Nutrition, University of Kuopio, Kuopio, Finland
6 shared publications Anna-Maija Tuomi
Orion Corporation ORION PHARMA FINLAND, Espoo, Finland
1 shared publication- Anne Tammi
The Research Centre of Applied and Preventive Cardiovascular Medicine and the Department of Pediatrics, University of Turku, Turku, Finland
1 shared publication E J Wallis
1 shared publicationHannele Savonius
From the Helsinki City Maternity Hospital, Helsinki, the
1 shared publicationHannu Vanhanen
1 shared publication
Latest Publications
- 1 December 2010
- Published by Taylor & Francis in Clinical Lipidology
- Vol. 5 (6) , 827-833
Plant stanol consumption for cardiovascular health: what do we know about efficacy and safety?
- 1 December 2010
- Published by Taylor & Francis in Clinical Lipidology
- Vol. 5 (6) , 827-833
Plant stanol consumption for cardiovascular health: what do we know about efficacy and safety?
- 1 April 2007
- Published by Elsevier in Clinica Chimica Acta
- Vol. 379 (1-2) , 53-58
Blood glucose and the metabolism of cholesterol in coronary patients with and without simvastatin treatment
- 1 April 2007
- Published by Elsevier in Clinica Chimica Acta
- Vol. 379 (1-2) , 53-58
Blood glucose and the metabolism of cholesterol in coronary patients with and without simvastatin treatment
- 1 September 2002
- Vol. 3 (9) , 1318-23
Combination therapy with statins.
Statins effectively inhibit cholesterol synthesis and are currently the most commonly used drugs for the treatment of hypercholesterolemia. However, patients with familial hypercholesterolemia and those unwilling to take, or who cannot tolerate statins, and patients with combined hyperlipidemia require a combination treatment. Statins combined with cholesterol malabsorption, caused, e.g., by plant stanol esters or ezetimibe (Schering-Plough Corp/Merck & Co Inc), or with bile acid malabsorption, caused by bile acid binding resins or guar gum, inhibit compensatory increases in cholesterol synthesis and effectively lower LDL cholesterol levels. Combination therapy of statins with fibrates should be controlled by lipidology experts. Recent information on indications and advantages of combining statins with n-3 fatty acids, hormone replacement therapy, or niacin, will also be discussed.
- 1 September 2002
- Vol. 3 (9) , 1318-23
Combination therapy with statins.
Statins effectively inhibit cholesterol synthesis and are currently the most commonly used drugs for the treatment of hypercholesterolemia. However, patients with familial hypercholesterolemia and those unwilling to take, or who cannot tolerate statins, and patients with combined hyperlipidemia require a combination treatment. Statins combined with cholesterol malabsorption, caused, e.g., by plant stanol esters or ezetimibe (Schering-Plough Corp/Merck & Co Inc), or with bile acid malabsorption, caused by bile acid binding resins or guar gum, inhibit compensatory increases in cholesterol synthesis and effectively lower LDL cholesterol levels. Combination therapy of statins with fibrates should be controlled by lipidology experts. Recent information on indications and advantages of combining statins with n-3 fatty acids, hormone replacement therapy, or niacin, will also be discussed.
- 1 January 2002
- Vol. 118 (19) , 1967-73
[Combination therapy of hypercholesterolemia].
- 1 July 2001
- Published by Oxford University Press (OUP) in The Journal of Nutrition
- Vol. 131 (7) , 1942-1945
Dietary Plant Sterols Alter the Serum Plant Sterol Concentration but Not the Cholesterol Precursor Sterol Concentrations in Young Children (The STRIP Study)
Plant sterol supplementation reduces serum cholesterol concentration but may increase serum plant sterol concentrations, especially in children. We determined whether natural dietary plant sterols derived mainly from vegetable oil or margarine in early childhood affect serum concentrations of plant sterols (campesterol and sitosterol) and cholesterol precursor sterols (Δ-8 cholestenol, desmosterol, and lathosterol), reflecting endogenous cholesterol synthesis. We measured the serum sterol concentrations using gas liquid chromatography in 20 healthy 13-mo-old intervention children in a randomized, prospective study designed to decrease exposure of the children to known environmental atherosclerosis risk factors and in 20 control children. The diet of the intervention children was rich in plant sterols due to replacement of milk fat with vegetable fat, whereas the diet of the control children contained only small amounts of plant sterols. The intervention children consumed twice as much plant sterols as the control children (P < 0.001). Their serum concentrations of campesterol and sitosterol were 75% and 44% higher, respectively, than those in the control children (P < 0.001 for both), but serum cholesterol precursor sterol concentrations did not differ between the two groups. We conclude that doubling dietary plant sterol intake almost doubles serum plant sterol concentrations in 13-mo-old children, but has no effect on endogenous cholesterol synthesis. Relative intestinal absorption of natural plant sterols from the diet in early childhood is similar to that in adults.
- 1 July 2001
- Published by Oxford University Press (OUP) in The Journal of Nutrition
- Vol. 131 (7) , 1942-1945
Dietary Plant Sterols Alter the Serum Plant Sterol Concentration but Not the Cholesterol Precursor Sterol Concentrations in Young Children (The STRIP Study)
Plant sterol supplementation reduces serum cholesterol concentration but may increase serum plant sterol concentrations, especially in children. We determined whether natural dietary plant sterols derived mainly from vegetable oil or margarine in early childhood affect serum concentrations of plant sterols (campesterol and sitosterol) and cholesterol precursor sterols (Δ-8 cholestenol, desmosterol, and lathosterol), reflecting endogenous cholesterol synthesis. We measured the serum sterol concentrations using gas liquid chromatography in 20 healthy 13-mo-old intervention children in a randomized, prospective study designed to decrease exposure of the children to known environmental atherosclerosis risk factors and in 20 control children. The diet of the intervention children was rich in plant sterols due to replacement of milk fat with vegetable fat, whereas the diet of the control children contained only small amounts of plant sterols. The intervention children consumed twice as much plant sterols as the control children (P < 0.001). Their serum concentrations of campesterol and sitosterol were 75% and 44% higher, respectively, than those in the control children (P < 0.001 for both), but serum cholesterol precursor sterol concentrations did not differ between the two groups. We conclude that doubling dietary plant sterol intake almost doubles serum plant sterol concentrations in 13-mo-old children, but has no effect on endogenous cholesterol synthesis. Relative intestinal absorption of natural plant sterols from the diet in early childhood is similar to that in adults.
- 1 April 2000
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 79 (4) , 260-264
Oral guar gum, a gel-forming dietary fiber relieves pruritus in intrahepatic cholestasis of pregnancy
- 1 April 2000
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 79 (4) , 260-264
Oral guar gum, a gel-forming dietary fiber relieves pruritus in intrahepatic cholestasis of pregnancy
Cholestanol and survival with simvastatin
# More data are needed {#article-title-2} EDITOR—Miettinen and colleagues identify a subgroup of Finnish patients with high cholestanol ratios who gained no benefit from statin treatment.1 They suggest that such patients have a low rate of cholesterol synthesis but a high rate of cholesterol absorption and that drugs that block the synthesis of cholesterol therefore do not improve survival. Surprisingly, they presented no data on the falls in serum cholesterol concentrations observed with simvastatin treatment within each cholestanol quarter. This information is essential to fully understand the link between high cholestanol ratio and the smaller reduction …
Cholestanol and survival with simvastatin
# More data are needed {#article-title-2} EDITOR—Miettinen and colleagues identify a subgroup of Finnish patients with high cholestanol ratios who gained no benefit from statin treatment.1 They suggest that such patients have a low rate of cholesterol synthesis but a high rate of cholesterol absorption and that drugs that block the synthesis of cholesterol therefore do not improve survival. Surprisingly, they presented no data on the falls in serum cholesterol concentrations observed with simvastatin treatment within each cholestanol quarter. This information is essential to fully understand the link between high cholestanol ratio and the smaller reduction …